Invention Grant
- Patent Title: Galenic formulations of organic compounds
- Patent Title (中): 有机化合物的Galenic配方
-
Application No.: US11153728Application Date: 2005-06-15
-
Publication No.: US08007824B2Publication Date: 2011-08-30
- Inventor: Petra Gisela Rigassi-Dietrich , Martin Schmid
- Applicant: Petra Gisela Rigassi-Dietrich , Martin Schmid
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Lisa M Matovcik
- Main IPC: A61K9/20
- IPC: A61K9/20
Abstract:
The present invention relates to a solid oral dosage form comprising a therapeutically effective amount of aliskiren, or a pharmaceutically acceptable salt thereof, and wherein the active ingredient is present in an amount of more than 46% by weight based on the total weight of the oral dosage form.
Public/Granted literature
- US20060018960A1 Galenic formulations of organic compounds Public/Granted day:2006-01-26
Information query
